High Blood Pressure (Hypertension) Completed Phase 3 Trials for Candesartan cilexetil (DB00796)

Also known as: HTN / Hypertension(HTN) / Hypertensive / Hypertension / High Blood Pressure / Blood High Pressure / Blood Pressure, High / High Blood Pressures / Blood pressure high / Essential (primary) hypertension / HT / HBP / Hypertension NOS / Hypertension arterial

IndicationStatusPhase
DBCOND0040789 (High Blood Pressure (Hypertension))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01984164CAndesartan vs LIsinopril Effects on the BRainPrevention
NCT00000620Action to Control Cardiovascular Risk in Diabetes (ACCORD)Prevention
NCT00227318TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention TrialPrevention
NCT00244621Atacand Dose Ranging in Hypertensive Pediatric Subjects 1 Year to Less Than 6 Years of AgeTreatment
NCT00383929Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mgTreatment
NCT00434967Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and PlaceboTreatment
NCT00690612Study to Characterize the Long-term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years (Hypertension in Pediatrics)Treatment
NCT01135212The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential HypertensionTreatment
NCT01613209Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ AmlodipineTreatment
NCT02770261Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R208 and Each MonotherapyTreatment